David Dreman

Last Update: 05-15-2017

Number of Stocks: 241
Number of New Stocks: 3

Total Value: $175 Mil
Q/Q Turnover: 5%

Countries: USA
Details: Top Buys | Top Sales | Top Holdings  Embed:

David Dreman' s Profile & Performance

Profile

David Dreman is the founder and Chairman of Dreman Value Management, LLC and also serves as the firm's Chief Investment Officer. A regular columnist for Forbes for 25 years, Mr. Dreman's recent best-selling book, "Contrarian Investment Strategies: The Next Generation?" was published in the spring of 1998.

Web Page:http://www.dreman.com/news/

Investing Philosophy

The Contrarian and the value guru, Dreman's investment philosophy is based on low P/E approach to stock selection. The philosophy at Dreman Value Management: "We invest in undervalued companies that exhibit strong fundamentals, above-market dividend yields and historic earnings growth, which our analysis indicates will persist. Our strategy is to own strong, fundamentally sound companies and to avoid speculative stocks or potential bankruptcies." They believe that the markets are not perfectly efficient, and that behavioral psychology influences investor actions and reactions.

Total Holding History

Performance of Large Cap Value Composite

YearReturn (%)S&P500 (%)Excess Gain (%)
20147.5713.69-6.1
201333.1432.390.8
201212.3316-3.7
3-Year Cumulative60.9 (17.2%/year)74.6 (20.4%/year)-13.7 (-3.2%/year)
2011-8.032.11-10.1
201014.7215.06-0.3
5-Year Cumulative69.7 (11.2%/year)105.1 (15.5%/year)-35.4 (-4.3%/year)
200926.9126.460.5
2008-44.97-37-8.0
2007-1.375.49-6.9
200617.515.791.7
20057.714.912.8
10-Year Cumulative48 (4%/year)109.4 (7.7%/year)-61.4 (-3.7%/year)
200412.6510.881.8

Top Ranked Articles

Undervalued Financial Services Companies Among Top Buys Low prices relative to the fair value increase value potential
Among companies trading on the New York Stock Exchange and Nasdaq, financial services companies currently trade below their fair values. Read more...
Own Meritorious Businesses, not Stock Markets What the space race did for tech in the 1960s the internet might be doing for it today
The current circumstance in the U.S. stock market remind us of the mid-1960s. We thought it would be helpful to review what was going on back then and what took place in the following 16 years. It makes us believe that you want to own wonderful businesses and de-emphasize trust in the stock market’s ability to meet the financial goals of long-duration investors. Read more...
Value Investors Avoided Deutsche Bank and 2 Other European Financials They were the least-held in the sector
Value gurus mostly exited Deutsche Bank (NYSE:DB) before its stock tumbled this month on news it might have to pay a large fine related to the financial crisis. While many maintain positions in other European banks as fear weighs on stocks in the sector, they are avoiding two almost as much as Deutsche Bank: Banco Santander SA (NYSE:SAN) and Lloyds Banking Group PLC (NYSE:LYG). Read more...
Divestitures Dominate Dreman's Top 10 Transactions in 2nd Quarter Financial services and energy companies account for most of transactions
Seven of David Dreman (Trades, Portfolio)’s top 10 transactions in the second quarter were exits from positions that have been in Dreman Value Management’s portfolio for most of the past six years. Dreman is the founder and chairman of the investment company. Read more...
Gilead Sciences Must Answer to Investors After a Disappointing 2016 Investors are concerned about the company's lack of a plan for the future
Gilead Sciences Inc. (NASDAQ:GILD) delivered a poor performance last year. The stock lost over 24% in 2016, caused by a drop in sales of products that treat hepatitis C. According to Ben Levinsohn in a Barron's article, the decline was also attributed to the company’s lack of a plan for the future. Read more...
» More David Dreman Articles

Commentaries and Stories

  • Currently 3.00/5

Rating: 3.0/5 (1 vote)

6 Stocks With Rising EPS DCF calculator gives wide margins of safety Chuck Royce,David Dreman,Paul Tudor Jones,Steven C - 6 Stocks With Rising EPS
Companies with growing earnings per share (EPS) are often good investments as they can return a solid profit to investors. Here is a selection of the most undervalued companies that have five-year growing EPS, according to the DCF calculator. More...

  • Currently 0.00/5

Rating: 0.0/5 (0 votes)

David Dreman Buys JPMorgan, Kroger, Reynolds Guru's largest 1st-quarter purchases David Dreman,Jim Simons,Pioneer Investments,Barrow - David Dreman Buys JPMorgan, Kroger, Reynolds
David Dreman (Trades, Portfolio) is the founder and chairman of Dreman Value Management LLC and also serves as the firm's chief investment officer. During the first quarter the guru bought shares in the following stocks. More...

  • Currently 5.00/5

Rating: 5.0/5 (1 vote)

Own Meritorious Businesses, not Stock Markets What the space race did for tech in the 1960s the internet might be doing for it today David Dreman - Own Meritorious Businesses, Not Stock Markets
The current circumstance in the U.S. stock market remind us of the mid-1960s. We thought it would be helpful to review what was going on back then and what took place in the following 16 years. It makes us believe that you want to own wonderful businesses and de-emphasize trust in the stock market’s ability to meet the financial goals of long-duration investors. More...

VALUE, MARKETS, CONTRARIAN, TECH


  • Currently 0.00/5

Rating: 0.0/5 (0 votes)

Insiders Invest in National General Holdings CEO, executive vice president purchase 74,978 shares total David Dreman, Scott Black - Insiders Invest In National General Holdings
CEO Barry Karfunkel and Executive Vice President Robert Karfunkel purchased a combined 74,978 shares of National General Holdings Corp. (NASDAQ:NGHC) on March 27 and March 28, according to SEC filings. More...

  • Currently 4.00/5

Rating: 4.0/5 (1 vote)

Is Williams-Sonoma a Better Bargain Than Ever? The retailer's investment prospects after its recent price decline Joel Greenblatt,David Dreman,Ray Dalio,Ken Fisher - Is Williams-Sonoma A Better Bargain Than Ever?
(Published by Nicholas McCullum on March 19) More...

DIVIDENDS, RETAIL


  • Currently 0.00/5

Rating: 0.0/5 (0 votes)

AbbVie Regimen Recommended for HCV Infection VIEKIRAX + EXVIERA shows high cure rates in GT1b HCV patients David Dreman,Joel Greenblatt,Ken Fisher,Mario Gabe - AbbVie Regimen Recommended For HCV Infection
AbbVie Inc. (NYSE:ABBV) communicated through the PRNewswire Monday that it received a positive feedback from the European Committee for Medicinal Products for Human Use (CHMP) about the possibility of using VIEKIRAX plus EXVIERA in a combined therapy of eight weeks to treat chronically genotype 1b HCV-infected adult patients. More...

  • Currently 0.00/5

Rating: 0.0/5 (0 votes)

AbbVie Declares Quarterly Dividend Analysts forecast increases in 2017 EPS and sales David Dreman, Joel Greenblatt, Mario Gabelli, Ken  - AbbVie Declares Quarterly Dividend
AbbVie Inc. (NYSE:ABBV) annouced a quarterly dividend of 64 cents per share on Feb. 16. More...

  • Currently 0.00/5

Rating: 0.0/5 (0 votes)

AbbVie's Hepatitic C Treatment Under Accelerated Review by EMA Treatment is still waiting for FDA approval David Dreman,Joel Greenblatt - AbbVie's Hepatitic C Treatment Under Accelerated Review By EMA
 AbbVie Inc. (NYSE:ABBV) announced Tuesday through the PR Newswire that the European Medicines Agency has validated its marketing authorization application. The company's application seeks permission to rapidly bring its “investigational, pan-genotypic regimen of glecaprevir (ABT-493)/pibrentasvir (ABT-530) (G/P)” to the market. More...

  • Currently 0.00/5

Rating: 0.0/5 (0 votes)

Goldcorp Sells Cerro Blanco to Bluestone Resources Miner sells interest for $18 million David Dreman,First Eagle Investment - Goldcorp Sells Cerro Blanco To Bluestone Resources
Goldcorp Inc. (NYSE:GG) announced Wednesday it agreed to sell its 100% interest in the Cerro Blanco gold-silver project in Guatemala to Bluestone Resources Inc. (TSXV:BSR). More...

  • Currently 0.00/5

Rating: 0.0/5 (0 votes)

HollyFrontier Upgraded by Deutsche Bank The firm set a target price of $38 David Dreman,Keeley Asset Management Corp - HollyFrontier Upgraded By Deutsche Bank
HollyFrontier Corp. (NYSE:HFC) has been upgraded by Deutsche Bank, which now suggests buying shares of the refining company. Prior to this rating, Deutsche Bank released a hold on shares of HollyFrontier. More...

  • Currently 0.00/5

Rating: 0.0/5 (0 votes)

Desjardins Capital Markets Picks Goldcorp for 2017 Company's outlook on output and costs will be appealing for many years First Eagle Investment,David Dreman,Mario Gabelli - Desjardins Capital Markets Picks Goldcorp For 2017
Goldcorp Inc. (NYSE:GG) appears at the top of the list of Desjardins Capital Markets for the large-cap stocks that the firm recommends buying for 2017. The firm says the company “will be able to illustrate an attractive multiyear guidance outlook on both production and costs,” as reported by the Financial Post. More...

  • Currently 0.00/5

Rating: 0.0/5 (0 votes)

5 Best Contrarian Stocks for Your Portfolio Here's a breakdown of the 5 top stocks based on the Contrarian Approach David Dreman - 5 Best Contrarian Stocks For Your Portfolio
(This article appeared first on The Stock Market Blueprint Blog.) More...

VALUE STOCKS, QUICK PICKS, LONG, CONTRARIAN STOCKS, DAVID DREMAN


  • Currently 0.00/5

Rating: 0.0/5 (0 votes)

Gilead Sciences Must Answer to Investors After a Disappointing 2016 Investors are concerned about the company's lack of a plan for the future David Dreman,John Rogers - Gilead Sciences Must Answer To Investors After A Disappointing 2016
Gilead Sciences Inc. (NASDAQ:GILD) delivered a poor performance last year. The stock lost over 24% in 2016, caused by a drop in sales of products that treat hepatitis C. According to Ben Levinsohn in a Barron's article, the decline was also attributed to the company’s lack of a plan for the future. More...

  • Currently 0.00/5

Rating: 0.0/5 (0 votes)

Mean Reversion and the Bell Curve The pressure to outperform all the time leads stock pickers to constantly seek mean reversion trades David Dreman,Warren Buffett - Mean Reversion And The Bell Curve
Over a three-year time period, stock prices tend to mean revert. This has spawned numerous investment approaches that try to squeeze capital gains out of those reversions. Classic deep value investing, as popularized by Benjamin Graham at Columbia Business School, taught that you would succeed by buying 50-cent dollars and selling them when and if they reverted to the mean. The "Dogs of the Dow" strategy of buying the 10 highest-yielding Dow stocks was born out of mean reversion. More...

MEAN REVERSION, VALUE INVESTING, WARREN BUFFETT


  • Currently 0.00/5

Rating: 0.0/5 (0 votes)

David Dreman Gains, Increases Multiple Positions in 3rd Quarter The guru heavily invested in 2 holdings David Dreman - David Dreman Gains, Increases Multiple Positions In 3rd Quarter
David Dreman (Trades, Portfolio) is the founder and chairman of Dreman Value Management LLC and also serves as the firm's chief investment officer. During the third quarter, the guru’s largest buys were the following: More...

  • Currently 0.00/5

Rating: 0.0/5 (0 votes)

Goldcorp Downgraded by BMO Capital The firm downgraded the miner to market perform with a target price of $15 David Dreman,First Eagle Investment - Goldcorp Downgraded By BMO Capital
Goldcorp Inc. (NYSE:GG) has been downgraded by BMO Capital Markets from outperform to market perform with a new target price of $15 per share, down 34.8% from the previous target price of $23 per share. More...

  • Currently 0.00/5

Rating: 0.0/5 (0 votes)

AbbVie Files for Approval of Hepatitis C Treatment in the US The application is backed by relevant results and the company will apply in Europe in the first quarter of 2017 David Dreman,Joel Greenblatt - AbbVie Files For Approval Of Hepatitis C Treatment In The US
AbbVie (NYSE:ABBV) announced today through PRNewswire that it has filed a New Drug Application (NDA) with the U.S. Food and Drug Administration for its “investigational, pan-genotypic regimen of glecaprevir/pibrentasvir (G/P).” More...

  • Currently 0.00/5

Rating: 0.0/5 (0 votes)

David Dreman Sells St. Jude Medical, Ford Contrarian investor nearly closes stake in medical company David Dreman - David Dreman Sells St. Jude Medical, Ford
David Dreman (Trades, Portfolio) is the founder and chairman of Dreman Value Management and also serves as the firm's CIO. The guru made the following sales during the third quarter. More...

  • Currently 0.00/5

Rating: 0.0/5 (0 votes)

Goldcorp, Eldorado Gold Announce Management Changes Mining companies appoint new leadership Charles Brandes,David Dreman - Goldcorp, Eldorado Gold Announce Management Changes
Eldorado Gold Corp. (NYSE:EGO) and Goldcorp Inc.(NYSE:GG) announced changes in their top management today. More...

  • Currently 0.00/5

Rating: 0.0/5 (0 votes)

Newmont May Book up to $1.2 Billion to Shut Down Peru Mine The largest gold producer in the US estimates higher than initially expected additional costs David Dreman,Donald Smith,Mario Gabelli,First Eagl - Newmont May Book Up To $1.2 Billion To Shut Down Peru Mine
Newmont Mining Corp. (NYSE:NEM) says that it may book approximately $1 billion or even $1.2 billion noncash impairment charge in the last quarter due to a higher than initially assessed value of “the asset retirement obligation at the mine of between $400 million and $500 million in the fourth quarter” for the shutting down of Yanacocha, the Peruvian mine, as reported Wednesday by Reuters.com. More...

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}
FEEDBACK